CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Botulinum Toxin for Treating Primary Focal Hyperhidrosis in Adult Patients: Clinical Effectiveness

Last updated: July 13, 2020
Project Number: RB1503-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of botulinum toxin for treating primary focal hyperhidrosis in adult patients?

Key Message

One health technology assessment, one randomized controlled trial, and one non-randomized study were identified regarding the clinical effectiveness of botulinum toxin for treating primary focal hyperhidrosis in adult patients.